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1  Introduction
While competition has rapidly become knowled-
ge and technology based, companies need to effecti-
vely manage their technological assets in order to
realize any potential inherent in their intangibles
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and to benefit from their innovation investments
(Chesbrough, 2003; Teece, 1986). Ford (1988) pro-
posed technology licensing as one of the forms for
exploiting technology, where knowledge is the eco-
nomic good exchanged, in the form of technolo-
gies, patents, ideas and know-how (Grandstrand,
2000). This research concentrates on technology
licensing (further on called licensing), which may
be motivated by some monetary and non-mone-
tary drivers, enabling firms to realize a new mar-
ket entry (Koruna, 2004b; Reitzig, 2004; Arora et
al., 2001; Grindley and Teece, 1997; Veugelers and
Cassiman, 1999). Practically, licensing for the mar-
ket entry purpose reduces the entry costs when
accessing a market (Fosfuri, 2004; Birkenmeier,
2003).  
Guadamuz (2005) defined technology licensing
as “the transfer of technology by means of a con-
tract of industrial property rights”. Moreover, a
licensing agreement may also transfer protected
or unprotected know-how, training of specialists,
transfer of procedures and technical assistance.
Licensing agreement is a result of technology licen-
sing and it is constituted by a sourcing firm pur-
chasing the rights to another firm’s patents or tech-
nology for a lump sum payment and/or royalties
(Hagedoorn and Hesen, 2007). Licensors are firms
that own the essential patents and licensees are
firms that purchase the right to use these patents
(Joshi and Nerkar, 2011). Particularly, this paper
explores the use of licensing for the foreign mar-
ket entry purpose.
Researchers claim (Bianchi et al., 2009; Birken-
meier, 2003; Escher, 2003) that the main barrier to
the successful licensing is a lack of appropriate
management of it. Licensing management explo-
res all the managerial activities that companies
deal with when engaged in technology licensing.
There are firms that experience considerable mana-
gerial difficulties with it, whereas others realize
enormous benefits (Elton et al., 2002; Lichtentha-
ler and Ernst, 2006, 2007). Research on the manage-
ment of technology licensing activities is still rela-
tively limited and previous works do not address
particularly the managerial challenges (Nakamu-
ra and Odagiri, 2005). Some research gives insights
on the aggregated industry level, but do not explo-
re closely how do firms manage their technology
licensing activities (Anand and Khanna, 2000; Arora
et al., 2001). There are works that have previously
focused on the licensing outcomes, but have not
concentrated on the managerial activities leading
to these outcomes (Kim and Vonortas, 2006; Nagao-
ka and Kwon, 2006). However, as far as the aut-
hors’ knowledge, none of the previous works explo-
re the management of technology licensing, obser-
ved as a new market entry mode.
This article aims to give a first step towards clo-
sing the research gap in the research on technolo-
gy licensing as a market entry mode, by addressing
the following question: How firms manage their
licensing activities, used in order to enter foreign
markets? This question is explored by analyzing the
empirical evidence coming from explorative case
studies from the four leading companies in the Ita-
lian pharmaceutical and biotech sector. The paper
starts from the Duning’s OLI framework from the
market entry mode literature, combined with the
process view perspective from the technology
management literature and some elements intro-
duced in the Dynamic Capabilities perspective. The
key findings indicate two points: (i) companies
adopt the process view perspective for managing
technology licensing as the foreign market entry
mode and (ii) throughout the stages of this pro-
cess firms tend to develop their dynamic capabili-
ties (sensing, seizing and reconfiguring).
This article is structured as follows. The second
section will give some theoretical foundations from
the relevant literature. Section three will explain
closer the research approach and the methodolo-
gy applied. In section five the main findings will be
discussed. Section six will conclude with the main
ideas deriving from the paper and with the possi-
ble directions for the future research. The outputs
of a research target at developing a systematic ana-
lysis of the critical managerial issues to be faced
during technology licensing as the market entry
mode.  
2 Literature Review
Starting upon the definition of technology licen-
sing given by Guadamuz (2005) (“the transfer of
technology by means of a contract of industrial
property rights”), a brief literature is given on
management of technology licensing used as a
foreign market entry mode. In this context, the
technology management and the foreign market
entry mode literature were reviewed.
2 . 1  Technology Licensing in Technology
Management Literature
There are many works on technology licensing,
which are sole theory and do not address manage-
rial challenges (Nakamura and Odagiri, 2005). In
order to manage licensing properly, researchers
stress the importance of strategic openness in the
firms (Chesbrough, 2007; Davis and Harrison, 2001).
Companies should be shifting from closed to open
licensing strategy (Chiaroni, et al., 2010), which
does not limit licensing activities only to the trans-
fer of internally unused technology (Dodgson et
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al., 2006; Prugl and Schreier, 2006), but employs
an active licensing with clear strategic goals. Anot-
her point states that companies should establish
a formal licensing strategy (Pitkethly, 2001; Davis
and Harrison, 2001; Rivette and Kline, 2000), used
as a tool for achieving monetary and strategic bene-
fits. There are papers indicating that companies
need to implement an active strategy, where they
actively seek for licensing opportunities (Fosfuri,
2006; Kim and Vonortas, 2006). Several authors
support the notion that inter-firm collaboration
has shown that managing technology transactions
requires a process view (Bianchi et al., 2009; Hoff-
mann, 2005; Chiesa and Manzini, 1998). Similarly,
some researchers highlight the importance of a
systematic licensing process, which may start upon
the technology sale process from Chiaroni, et al.
(2010). In essence, the idea is to systematize the
technology licensing process in several stages and
to facilitate management of its activities (Koruna,
2004a; Tschirky et al., 2004). The industry experts
and the indications from the researches agree on
the fact that a formalized process is important, alt-
hough the specific number of process stages may
vary (Ernst, 2002; Cooper and Kleinschmidt, 1995).
Accordingly, this process does not usually follow
all the steps sequentially, but iteratively including
feedback loops and reiterating some phases. In the
Chiaroni et al. (2010) paper, the major steps of the
technology sales process are planning, intelligence,
negotiations with potential licensees, technology
transfer, and control. Each stage is comprised of
specific managerial challenges and main tasks to
be performed. These activities are usually complex,
differing in every licensing case, and need to have
a systematic management that will consider the
entire process. The process aims to allow compa-
nies to achieve an optimum management of all
activities in licensing. So, licensing as a mode for
the foreign market entry can be approached as a
managed and structured process with the clear
aim.
As managerial and organizational processes
lead to the development and deployment of firm’s
dynamic capabilities (Helfat et al., 2007), manage-
ment of the process of licensing within the firm is
closely related to its dynamic capabilities develop-
ment and deployment. Teece (2007) explains that
the dynamic capabilities framework entails the fol-
lowing components: sensing opportunities and
threats, seizing opportunities and reconfiguration
of resources. By structuring the technology licen-
sing process, the abilities of companies to sense,
seize and reconfigure, are being developed and
enstrengthened. Initially, the dynamic capabilities
approach was made for analysis of the sources of
wealth creation and capture by firms (Teece et al.,
1997). The Dynamic Capabilities Framework show-
ed that companies need to align their resources
with the demands of the market through sensing,
seizing and reconfiguring activities (Teece, 2007).
Firstly, firms need to focus on sensing activities,
which are seen through seeking for the new oppor-
tunities. Previous works state that the basic routi-
nes of the sensing capability are: (i) generating
market intelligence (Galunic and Rodan, 1998) and
(ii) disseminating market intelligence (Kogut and
Zander, 1996). In this phase, companies scan, explo-
re and analyze the information from their surroun-
ding and in this manner discover existing and crea-
te new opportunities. Bianchi et al. (2010) develop
a step-by-step methodology, based on the TRIZ
idea, for the identification of opportunities for licen-
sing a firm’s technologies outside its core business,
which fits the purpose of the sensing phase. Moreo-
ver, firms must manage and filter the informati-
on, which will enable them to identify the infor-
mation of interest (Ocasio, 1997). Secondly, the sei-
zing the opportunity follows, which is related to
pursuing of the new initiatives (Van den Bosch, Vol-
berda and De Boer, 1999) and  seizing opportuni-
ties (Teece, 2007), by considering acquiring, assi-
milating, transforming, and exploiting knowledge
(Zahra and George, 2002), and responding to mar-
ket intelligence (Teece, 2007). Thirdly, after sen-
sing and seizing the opportunities, the reconfigu-
ration of resources initiates. Among others, recon-
figuration is accomplished by managing strategic
fit of the process, observing the appropriateness
matters (Galunic and Rodan, 1998), timeliness mat-
ters (Zott, 2003) and efficiency matters (Kogut and
Zander, 1996). This research analyzes whether the
process view of technology licensing used for the
foreign market entry purpose allows firms to deve-
lop the three dynamic capabilities.
2 . 2  Technology Licensing in Foreign Market
Entry Mode Literature
Most of the international business literature
examines licensing in the new market entry modes
context (Aulakh et al., 2009). In the research on the
internationalization process models, academics
observe licensing from the transaction costs per-
spective and usually compare its efficiency with
other foreign market entry modes (like exports,
joint ventures and wholly owned subsidiaries
(Anderson and Gatignon, 1986; Buckley and Cas-
son, 1976; Contractor, 1984)). In general, this lite-
rature sees licensing as a low-commitment/low-
return entry mode, which companies use primary
to acquire some experiential knowledge on the
foreign markets before they continue further to
commit to this new market (Arora and Fosfuri,
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2000; Johanson and Vahlne, 1977). Initially licen-
sing was mainly applied as an alternative strategy
to FDI (Brouthers and Hennart, 2007; Goldschei-
der, 2002). Increased competition and faster pro-
duct and technology cycles have led companies to
make a thorough evaluation of their technology
portfolio, considering licensing as a commerciali-
zation strategy to generate additional revenues at
almost no additional cost. When the choice of the
market entry mode is in question, licensing is vie-
wed as a low investment, low risk/return alterna-
tive which provides least control to the licensing
firm (Woznick, 1996; Agarwal and Ramaswami,
1992).  This experiential knowledge of a foreign
market is especially valuable because some aut-
hors argue that net profit resulting from the licen-
sing transaction and received by the licensor is
lower than the net profit received by keeping the
technology in-house or licensing it to a firm’s sub-
sidiaries (Kotabe et al., 1996). Authors explain that
the major reason for this is seen in high transac-
tion and opportunity costs coming from the tech-
nology transfer to other firms. Dunnings’ OLI eclectic
paradigm, extensively used to compare the foreign
market entry mode choices (Terpstra and Yu, 1988;
Sabi, 1988; Kogut and Singh, 1988; Davidson and
McFetridge, 1985; Caves, 1982; Dunning, 1980), puts
a strong emphasis on factors influencing the pre-
ference for licensing versus FDI to enter foreign
markets (Dunning, 1993). Dunnings’ OLI eclectic
paradigm analyzes the foreign market entry mode
choices decisions in terms of ownership (O), loca-
tion (L), and internalization (I), or OLI. Each one of
the OLI factors has been associated with precise
advantages that can enhance the firm performance.
Further on, researchers present licensing as the
second-best entry strategy, which primarily enab-
les companies to extract residual value from matu-
re technologies (Telesio, 1979).
However, firms increasingly rely on licensing to
enter foreign markets and gain global competiti-
ve advantage (Fosfuri, 2006; Hill, 1992, 1997; Kota-
be et al., 1996). Only limited attention has been
paid to management activities of licensing as a
mode of entry, which can provide with an option
to grow when uncertainty is resolved favorably,
while also offering enough flexibility to abandon
the market in the event of negative information
(Ahsan and Musteen, 2011). In this sense, an impor-
tant issue not studied thoroughly in the foreign
market entry mode literature should answer ques-
tions on ‘‘how to license’’ in the foreign markets
rather than ‘‘whether to license’’ (Aulakh et al.,
2009). Similarly, in this work authors implement
the OLI perspective in the technology licensing
management, which companies exploit when enga-
ged in licensing for the foreign market entry pur-
pose.
The literature review on technology licensing
in technology management literature and foreign
market entry mode literature, points out on a gap
in the previous research, not explaining the mana-
gerial activities encountered by the companies that
engage in technology licensing for the foreign mar-
ket entry purpose. In order to untangle this over-
looked issue, this research observes the case stu-
dies originating from the leading Italian pharma-
ceutical and biotech companies that engage in
licensing for this purpose. The analysis adopts seve-
ral ideas from the reviewed literature, like the pro-
cess view of licensing aligned with the Dynamic
Capabilities framework and Dunnings’ OLI eclectic
paradigm. The next section provides more detai-
led information on the methodology applied.
3  Methodology
For the purpose of this research comparative
multiple case studies were applied (Yin, 2003),
because they enable an in-depth examination of
each case and also enable a cross-case comparison
(Eisenhardt and Graebner, 2007). As explained in
the previous sections, this paper is more focused
on answering ‘why’ and ‘how’ research questions,
which suite this methodology (Eisenhardt, 1989).
Different forms and approaches to the manage-
ment of licensing as a foreign market entry mode
have not been significantly documented, which
can be appropriately investigated and presented
with a qualitative approach. Relying on the theo-
retical sampling logic given by Siggelkow (2007),
this study has chosen to observe four leading Ita-
lian pharmaceutical and biotech firms. The phar-
maceutical and biotech industry was chosen, becau-
se these industries indicate a strong presence of
active licensors (Schilling, 2009; Kim, 2009; Arora
and Ceccagnoli, 2006; Rivette and Kline, 2000;
Grindley and Teece, 1997). Importantly, there is an
active market for technology in the chemical pro-
cesses (Arora et al., 2001). When setting up selecti-
on criteria on whether to include the company in
the research, the following was accounted: (i)
selected companies have been identified as active
licensors (ii) selected companies have already been
engaged in licensing in the foreign markets; (iii)
sample of companies was not limited to any firm
size. The “polar type” sampling procedure (Eisen-
hardt and Graebner, 2007) was not used, because
it was not necessary for the purpose of this research.
The overall performance of licensing was not an
issue of interest here, but the managerial activi-
ties met during technology licensing for the foreign
market entry purpose. However, pure theoretical
sampling was enough to allow experimental situa-
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tion, where the phenomenon of interest was stu-
died under particularly insightful circumstances
(Siggelkow, 2007). Finally, research results coming
from the exploratory case study analysis are not
statistically generalizable (Yin, 2003), but explora-
tory. The overall goal is analytically and theoreti-
cally to combine the existing body of knowledge
on technology licensing management from the
technology management research and research on
technology licensing coming from the foreign mar-
ket entry literature, in order to build a basis for futu-
re theoretical and empirical studies on technolo-
gy licensing management used as the foreign mar-
ket entry mode.
Preliminary list contained ten companies that
may fit the explained selection criteria. These firms
were identified in consultation with the experts
from the Licensing Executives Society Italia (LES
Italia), a nonprofit organization that operates in
the field of business law, intellectual property and
technology licensing, trademarks and intellectual
property. LES Italia has more than 300 members,
representing the largest firms, industrial organi-
zations, research institutes, law and patent firms
that aim to promote opportunities for licensing.
Afterwards, each of the firms was contacted in
order to gather information on the company and
to make and additional check whether it fits the
sampling criteria defined. Eventually, the final sam-
ple comprised of four firms that met all the crite-
ria stated above. In Table 1 some preliminary infor-
mation on the companies included in the sample
are provided.
In the data collection procedure, the research
mainly relied on the semi-structured personal inter-
views with the key informants. All the interviews
were conducted in the period between the Janua-
ry 2012 and May 2012. In each company the inter-
viewed persons were heads of licensing units. If
the firm didn’t have a dedicated licensing unit, eit-
her responsible person for the management of
research and technology, or person responsible for
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Firm Sector Total turnover
a
(# employees)c
# of patents
(# licensing
agreements)b
Interviewed  per-
sonnel
Company A1 Diagnostic 1.000.000(3000)
1500
(N.A.)d
- Integrated Research
Director
- Technology Oppor-
tunities Director
Company B Pharmaceutical 68.000(280)
7
(60)
- Head of Licensing &
Business Develop-
ment
- R&D Director
-International Sales
Manager
Company C Biopharmaceuti-cal
529.000
(800)
308
(N.A.)
- Marketing e and
International Sales
Director
- Head of Licensing
Unit
Company D Pharmaceutical 500.000(2000)
258
(50-60)
- Head of Business
Development
Tabl e 1  P r el imi n ar y I n formati on  on  th e sampl ed c ompan i es.
1 The names of the firms were omitted on purpose, as the interviewed personnel request.
a Total turnover in thousands of euro, as of 2010 (source: interviews and company archival data).
b Number of patents and number of licensing agreements (source: interviews, company archival data and company website).
c Calculated as full-time equivalent employees.
d N.A. = not available.
the international markets was interviewed. In all
the cases a second person, generally from R&D or
marketing department, was interviewed in order
to obtain a different assessment. Moreover, at least
one member of the top management team (if pre-
sent) was interviewed for each firm. A minimum
of three interviews for each company was made
and a total of thirteen thorough face-to-face inter-
views were used as a basis of this research. Inter-
viewing multiple respondents from each of the
firms was done with the aim to accomplish data
triangulation and to reduce the retrospective and
personal interpretation biases. All the interviews
lasted between 1 and 3 hours, they were digitally
recorded and manually transcribed by typing all
the interviews in the digital form. For this purpo-
se computer software called Express Scribe has
been engaged. Express Scribe is professional audio
player software designed to assist the transcripti-
on of audio recordings, which enables controlling
audio playback using a transcription keyboard (with
“hot” keys). This software was particularly useful,
while it enabled valuable features for transcribing
(like variable speed playback, multi-channel con-
trol, file management, etc.).  
Importantly, the documented information on
the management of technology licensing for the
foreign market entry purpose, but also general data
on the company, were collected through seconda-
ry sources (like internal documentation, project
reports and company web site). All the multiple
interviews and the documented data collected were
primarily used to triangulate the information gathe-
red. The Appendix A presents the major topics of
interest and the open-ended questions asked during
the interviews. All the major topics and the open-
ended questions from the Appendix A have served
as a research protocol, allowing the interviewer to
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Capability Brief Description Code Basic Routines to identify
Sensing Spotting and interpreting theopportunities
1.1
Generating market intelli-
gence (Galunic and Rodan,
1998)
1.2
Disseminating market intel-
ligence (Kogut and Zander,
1996)
Seizing Seizing and pursuing the opportu-nities
2.1
Acquiring, assimilating,
transforming, and exploi-
ting knowledge (Zahra and
George, 2002)
2.2 Responding to market intel-ligence (Teece, 2007)
Reconfiguring Reconfiguring assets
3.1 Appropriateness matters(Galunic and Rodan, 1998)
3.2 Timeless matters (Zott,2003)
3.3 Efficinecy matters (Kogutand Zander, 1996)
Tabl e 2  Oper ati on al i zati on  of th e dyn ami c  c apabi l i ti es (r el yi n g  on  some el emen ts fr om th e wor k  of 
Pavl ou an d El  Sawy, 201 1 ).
lead a semi-structured examination, but also to
keep the record of the interview procedure in the
case of replication or extension of the analysis (Yin,
2003).
When the data analysis started, firstly the col-
lected information was manipulated by relying on
the data categorization and contextualization tech-
niques (Miles and Huberman, 1999). Secondly, the
structured data analysis process was followed. This
process consisted of a preliminary within-case study
and an explanation building investigation, follo-
wed by a cross-case comparison. The investigati-
on in this research initiated by inducing whether
the companies from the sample applied any structu-
red process like approach in managing licensing as
the foreign market entry mode, which was sugges-
ted in the literature review section. In order to check
if within this licensing process in the companies
some of the elements of Dynamic Capabilities Fra-
mework were recognized (sensing, seizing and
reconfiguring) and developed, the Dynamic Capa-
bilities Framework had to be operationalized by
giving a set of activities that characterize each of
the dynamic capabilities. In Table 2 the list and
codes of these activities and criteria were provi-
ded, which was derived from the analysis of the
dynamic capabilities literature.
This operationalization was applied to identify
whether through the licensing process for the
foreign market entry purpose, firms develop these
dynamic capabilities. The structured procedures
for data collection and analysis, but also the semi-
structured interviews, were used in order to enhan-
ce the reliability of the research (Yin 2003). Table 3
(in the Appendix B) presents the brief description
of the companies studies, their examples of licen-
sing projects as the foreign market mode and des-
cribes the licensing phases identified.
4 Results and Discussion
This section presents and discusses on the main
findings from the case studies. Table 4 (given in
the Appendix B) gives the results of the analysis of
all the process in order to identify the dynamic capa-
bilities developed along the process. All the com-
panies involved in the research, recognized within
their foreign market entry strategy a strong exploi-
tation of licensing for this purpose. Integrated
Research Services and Technology Opportunities
Director interviewed in front of the Company A
explained that operating on a global scale is not
just a choice but also a necessity, because innova-
tion in pharmaceutical industry is costly and long
lasting, and the only way to obtain the return of
investment is to launch it on a world wide scale.
On average it takes 12 years from beginning of the
development to the market approval, costing bet-
ween $0.8-1 billion (Austin, 2006), and with high
attrition rate that allows only 2-3% of products to
actually be launched on the market),The findings
do not aim to categorize, but to present the con-
tent of the managerial activities coming from the
technology licensing process as the foreign mar-
ket entry mode. The process perspective helps aca-
demics to study, but also practitioners to carry out,
the management of technology licensing as the
foreign market entry mode.The interviews perfor-
med confirm that the phases taken from the paper
of Bianchi et al. (2011) considerably reflect the pro-
posed process stages. Furthermore, within the con-
text of this process some elements of the Dynamic
Capabilities Framework have been recognized, poin-
ting out that this process like approach enables
development of the dynamic capabilities for this
purpose.
4. 1  Planning
In the companies examined, the planning stage
does not have any observed specificities and it is
considered to be a part of the process of building
the company’s strategy to internationalize on
foreign markets. The reason for this finding can be
explained by the fact that in the choice of the sam-
ple, firms that already engage in active licensing
and engage in licensing in the foreign market have
been examined. So, they do not have the planning
phase, because in their case it is already implemen-
ted in their overall company strategy. The alignment
between the overall firm strategy, and internal and
external exploitation programs is the main activi-
ty actually performed in the planning stage. In the
interview with the Head of the Licensing Unit in
the Company D, she explained that her company
has already developed strategy to rely on techno-
logy licensing for the foreign market entry purpo-
se and that the whole process initiates with data
collection on the foreign market.
4. 2  Intelligence
This phase of the process has in previous stu-
dies been characterized by the technological and
market environment scan, the sale opportunities
identification, and the contractual mode choice
(Bianchi et al., 2011). When companies involved in
this research decide to enter the foreign market
they firstly start with the market seekingon which
market to enter and afterwards with partner see-
king within this market. Similar concept has been
recognized with other authors, explaining that
licensing is shaped by industry level and market
level related concepts (Walter, 2012). Partner see-
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king has been identified within the intelligence
phase of other similar research works (Bianchi et
al., 2011) and has been considered as highly impor-
tant. Further on, when they involve in the market
seeking, companies closely process the following
parameters: 
Freedom to operate: an in-depth study of the
state of the art in patents in order to check if there
is a already present on that market (see e.g. Com-
pany A and B); 
Exclusivity: evaluation of the exclusivity of
their product; whether firm can attain the allowan-
ce to produce and sell the product; presence and
availability of similar products on the market (see
e.g. Company A and D);
Cultural differences: observing how the gene-
ral business culture in the country fits firms’ ideas
for that market; if the cultural differences may faci-
litate or aggravate their presence in the market
(e.g. Company A managers give an example of
Japan, where the employees are loyal to the coun-
try on the first place, and afterwards to the com-
pany, see also Company B);
Market size: see e.g. Company B and D.
The market analysis is the foundation for the
partner seeking, which includes the evaluation of
the following features of potential partners:
Financial capabilities: financial foundations,
sales, company size (e.g. Company B states that
long decision timing in bigger companies may make
problems), see e.g. Company A, B, C and D;
Technical capabilities: portfolio of products,
possibility for cross-licensing, degree of specializa-
tion (e.g. when Company B licensed the product
for tumor in Canada, they explored the companies
that are active only for this specific tumor), expe-
rience (see e.g. Company A, B, C and D);
Commercial capabilities: presence in the field,
location of a partner (e.g. Company A manager
explains that suitable partners are in Princeton,
New Jersey, where the majority of world pharma-
ceutical industry is based and it is close to univer-
sity), presence in other markets (e.g. Company C
was seeking for a partner in Russia that was also
present in other former Soviet Union and Eastern
European markets), see e.g. Company A, B, C and
D.
Interestingly, the Company C has a fully forma-
lized intelligence process that has a step-by-step
procedure for the market analysis and the partner
analysis, based on the evaluation of potential mar-
kets and partners. The management of this pro-
cess is lead by the dedicated functional unit, spe-
cialized for the market intelligence, suggested by
other authors as well (Kale et al., 2002; Bianchi et
al., 2011A). This process initially aims to build a “Long
List” of pharmaceutical companies belonging to
the main National Trade Associations, after which
the public available information relevant to assess
partner’s “generic and specific requirements are
being gathered. Company C then filters the data
collected, firstly by excluding the companies with
an unfitting business model. The unfit companies
are recognized as the ones that base their business
on the generic drugs production, on the offer of
specialized R&D services, on exploitation of the
plain homeopathic treatment ideas, etc. In the next
step the in depth desk analysis and profiling of the
short listed companies is done by ranking of the
short listed companies. In the ranking Company C
observes their Product Portfolio Fit (therapeutic
field, number of drugs, the expertise they have on
the regulatory activities, presence in other mar-
kets) and Economic and Financial Soundness (finan-
cial foundation of the company). This procedure,
in the abstract level, may be employed in other
industries as well.
After the analysis of the interviews with the
managers, a strong presence of the routines that
develop the sensing dynamic capabilities has been
noticed. 100 percent of the companies from the
sample appear to be relying on the routines for
generation of the market intelligence (Galunic and
Rodan, 1998) and dissemination of the markets
intelligence (Kogut and Zander, 1996).
4. 3  Negotiation
The negotiation stage introduces the commu-
nication with the partners with the intention to
sell the technology and to establish the contractu-
al agreement (Bianchi et al., 2011). Negotiations
include several aspects that companies manage
when they rely on licensing in order to enter a
foreign market. It is considered as a particularly
risky stage, because companies need to disclose
certain information on their technology in order to
negotiate on the technology sale. The person from
the Company A responsible for managing the Tech-
nology Opportunities Department sees this phase
as a “complex process within the process, which
needs to be managed extremely cautiously “. All
the negotiations are performed in multiple stages
manner (see e.g. Company B) and they are concen-
trated around:
Commercial aspects: dealing with financial
indicators and returns (see e.g. Company A, B and
D);
Technical aspects: questions of approval for
the product on the market, timing and cross-licen-
sing (see e.g. Company A, B and D).
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It is important to stress that companies often
engage in “multiple- negotiations” (like in the case
of Company A). This situation is common when
there is a need for so called “stacking provision”,
which appears when a certain owner of a patent-
ed technology intends to manufacture products
under the license and for this purpose it needs to
obtain additional licenses from other parties who
own rights in related, actual or potentially overlap-
ping technologies. This is a case when a company
has to negotiate with more companies whose
patents they need for production of the current
product or whose patents overlap to some extent.
In any case in the negotiation phase firms can practi-
ce some methodologies that facilitate the overall
negotiations (like the Thompsons’ (2011) mixed-
motive negotiation techniques and some practi-
cal intangible-asset evaluation methods reviewed
in the paper from Smith and Parr (2000)).
The negotiation stage also allows enterprises
to build up their seizing dynamic capabilities. For
instance, companies A, C and D, show the signifi-
cant presence of evolution of their acquiring, assi-
milating, transforming, and exploiting knowledge
activities (Zahra and George, 2002), and market
intelligence response activities (Teece, 2007). By
definition, the seizing dynamic capability perfect-
ly fits into the main goals of the negotiation stage
of the process, but our analysis also puts forward
the notion that the presence of routines that enab-
le and expand this capability is identified in the
realization stage (like in the example of the Com-
pany C and Company D). Nevertheless, in 75 per-
cent of the companies (Company A, B and D) sei-
zing dominates the negotiation stage, and in 50
percent of the companies (Company C and D) it has
been also identified in the realization stage. In one
firm (Company D), the negotiation phase has an
important role for the deployment of the reconfi-
guration capability in the firm.
4. 4 Realization
After intelligence and negotiation firms arrive
to the realization phase, involving the actual trans-
fer of technology between the counterparts (Bian-
chi et al., 2011). The major hindrance appearing here
is caused by the tacit nature of knowledge, which
is difficult, long-lasting and expensive to transfer.
So, the managers from the firms studied try to cir-
cumvent this obstacle by continuing to provide the
support to the partner company even after the
transaction has officially been completed. In this
manner, partnering firms’ business and treatment
of the licensed technology is backed up by the licen-
sor firm. The realization stage in licensing process
for the purpose of the foreign market entry inclu-
des the two aspects:
Technology transfer: seen as pure transfer of
know-how and the supporting documentation
(Company A, B, C and D); 
Marketing support: for instance, Company C
makes a detailed marketing support for the part-
nering company, containing the information and
knowledge to enter the market (similar point obser-
ved in the Company D). 
This marketing support gives closer explanati-
ons on the experience of the company and their
previous partners in the foreign markets. It is made
with the aim to help partners in the new markets
to understand how the product works and what
its benefits on which they should focus are. The
marketing support is transferred to partnering com-
pany through trainings, seminars and written docu-
ments (similar point observed in the Company D).
This stage enables the development of the sei-
zing dynamic capabilities. In 50 percent of the com-
panies realization stage gives firms an opportuni-
ty to develop their seizing capability. Seizing and
reconfiguring capabilities are more active and ope-
rational capabilities in the company. So, it may be
concluded that the actual realization phase advan-
ces these two, operational capabilities.  
4. 5  Control
As stated in Bianchi et al. (2011) work, the con-
trol stage entails the monitoring of the partner’s
behavior and compliance with the contract. In the
licensing process used for a company to enter a
foreign market, two main points are controlled
after the realization of the technology transfer and
marketing support. These points include:
Contract management: introduced the con-
trol of the terms given in the contract, which inclu-
de the respect of intellectual property aspects and
the respect of the outlined commercial arrange-
ments (like the achievement of the minimum quan-
tities of sales and fulfillment of the time frame-
work given in the contract, as explained by Com-
pany B, C and D);
Alliance management: concentrated mainly
on the monitoring the heed of the commitments
of the partner company (see e.g. Company B and
C).
Both of the points presented above are control-
led on a pre-defined periodic basis relying on con-
ference calls, meetings, additional trainings and
written reports. The question of the size of the part-
ner company has a strong impact on the control
phase. Head of the Business Development in Com-
pany D explains that bigger companies are more
autonomous are and more difficult to follow. 
Control phase of the licensing process has allo-
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wed the formation of the reconfiguring dynamic
capability. In the 75 percent of the firms some ele-
ments that improve the appropriateness matters
(Galunic and Rodan, 1998), timeliness matters (Zott,
2003) and efficiency matters (Kogut and Zander,
1996) have been found. As the Head of Licensing
& Business Development in Company B said, after
the realization of the transfer of the technology,
the firm still continues to align the partner com-
pany with the points stated in the contract. This is
done with the aim to harmonize the timing and
the sales amount assigned in the contract.
The Figure 2 presents proposed process of tech-
nology licensing used as the foreign market entry
mode, which was developed relying on the findings
from this research. In the Figure 2, the main acti-
vities in each of the phases are presented and also
the dynamic capabilities which are developed along
the process.
5  Conclusion
An active technology licensing has become a
strategy exploited strongly within the firms. It will
certainly be seriously considered in the future in
the managerial research and within the compa-
nies themselves, because it enables companies to
achieve both financial and strategic benefits and
returns on their innovation efforts. However, the
technology licensing for the foreign market entry
purpose is complex and hard to manage. This paper
aimed to present the process view perspective,
which facilitates its management. To point out, the
identified process stages may not fit ideally within
the licensing as the foreign market entry mode in
all the firms. Different environments and contexts
of application of this process view may slightly vary,
like they varied also in the firms from our sample.
The papers also shows that the throughout the
licensing process used as the foreign market entry
mode, enables companies to develop three dyna-
mic capabilities (sensing, seizing and reconfigu-
ring), which are useful further on for the compa-
ny. This paper, however, has not explored the per-
formance issues resulting from the different ways
of management of the licensing process as the
foreign market entry mode, which is an interesting
venue for the future research. As this is a quanti-
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tative based analysis, it is not appropriate for gene-
ralizing the results. In any case, the process based
view can be appropriately examined by applying
the longitudinal panel data analysis, quantitative
research approach, which is one more suggestion
for the future research. 
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Appendix A
Interview Protocol
Company in general:
- Portfolio of activities, products/services 
- Firm information (size, businesses, industry, location, geographical location, products and services com-
mercialized, main financial figures)
Licensing activities:
- Technology licensing to enter foreign market (main goals, amount, frequency, people involved, reference
to one or more licensing projects)
- Firms’ degree of internationalization (presence in international market)
Licensing process:
- Technology licensing process identified ((i) planning; (ii) intelligence (identification and evaluation of
exploitation potential); (iii) negotiation; (iv) realization (one-directional or bi-directional technology
transfer); and (v) control; boundaries of each of the process stages) 
- Tasks/activities in process stages (management)
- Degrees of formalization (e.g. (i) formal structures - existence of procedural routines, (ii) informal structu-
res)
Dynamic Capabilities:
- Please indicate if the following activities appear during your licensing process used for the company to
enter a foreign market (indicate also in which process stages these activities appear):
- Sensing capability:
(i) generation of market intelligence
(ii) dissemination of the market intelligence 
- Seizing capability:
(i) responding to market intelligence
(ii) acquiring, assimilating, transforming, and exploiting knowledge 
- Reconfiguring capability:
(i) observing appropriateness matters 
(ii) observing  timeliness matters 
(iii) observing efficiency matters 
- Please discuss how practically you perform these activities
Uros Sikimic,  Federico Frattini and Vittorio Chiesa
Journal of Business Chemistry 2013, 10 (1)© 2013 Institute of Business Administration 16
Appendix B
Com
pany A
Com
pany
Com
pany A is an integrated
international group that
operates in life sciences
sectors (diagnostics, thera-
peutics, instrum
entation,
services).
- Turnover:over € 1 billion
(65% m
ade in foreign m
ar-
kets); data from
 2010, data
from
 2011 are sim
ilar and
slightly increased.
- Em
ployees:3000
- Core business:Internatio-
nal leader in im
aging diag-
nostics (wide range of pro-
ducts and solutions for all
diagnostic m
ethods), have
the biggest diagnostic cen-
tre in Italy (3-4 m
illion analy-
ses per year).
- Operates in:US, Canada,
Brazil, all Continental
Europe, UK, Ireland, China,
Japan and Scandinavia.
- Num
ber of licensing agree-
m
ents:Not available (1500
patents, m
ostly to form
 bar-
riers for the few break-
through patents).
Com
pany Info
The turning point for the com
pany
was in the '80s, when the Com
pany A
developed a new breakthrough agent
in radiological im
aging. On one side
this lead to big growth and producti-
on, but it was also a com
pany’s’ deci-
sion to becom
e truly international
com
pany, operating on a m
ultinatio-
nal basis. The Com
pany A m
ade a
decision not only to have licensees
for collecting royalties, but to estab-
lish full presence in the m
arket. This
presence was m
ainly through joint
ventures, where Com
pany A m
ade a
point of having a 51% of the venture
(because they really wanted to have
this joint venture as som
ething on
what they had control, gain direct
experience from
 the territories and
not to be seen as just a sim
ple col-
lector of royalties). M
ore recently,
som
e of the com
panies have becom
e
fully owned by Com
pany A, which is
their second step when entering a
new m
arket. Once the com
pany
learns how to behave, the situation is
m
ore m
ature to establish them
selves
as a fully owned com
pany.
Exam
ples of licensing projects as the
foreign m
arket entry m
ode
- Intelligence:Com
pany A has alerting services
that on weekly basis control patents of their
interests. Alerts go through som
e databases
which provide constant update on the given
keywords and areas that the com
pany wants
to keep under control (alerted on the patent
activities from
 other com
panies). W
hen com
-
pany seeks for a foreign partner, it observes
portfolio of patents and their degree of spe-
cialization (potential of cross-licensing), expe-
rience of a partner, business culture of the
local country (e.g. Com
pany A m
anagers give
an exam
ple of Japan, where the em
ployees
are first loyal to the country, then to the com
-
pany), location of a partner (e.g. suitable part-
ners are in Princeton, New Jersey, where the
m
ajority of world pharm
aceutical industry is
based, and it is close to the university).
W
hen com
pany wants to enter a new m
arket
it observes: Freedom
 to operate(an in-depth
study of the state of the art in patents in order
to check if there is a already present on that
m
arket); Exclusivity(how good is an exclusivi-
ty of their product: com
pany m
ay have the
allowance to produce and sell the product, but
very sim
ilar product m
ay be available on the
m
arket).
- Negotiation: Com
pany A negotiates around:
com
m
ercial aspects(financial indicators and
return), technical aspects (approval for the
product on the m
arket and cross-licensing). 
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Com
pany B
Com
pany
Com
pany B is a fam
ily
owned pharm
aceutical com
-
pany that is involved both in
developm
ent and m
anu-
facturing of the pharm
aceu-
tical products.
- Turnover:€68 m
illion (10%
in foreign m
arkets); incom
e
in royalties and down pay-
m
ents is around 2% and it is
decreasing.
- Em
ployees:280 
- Core business:Beyond the
m
ore traditional activities in
the osteoarticular field and
in the product pipeline reno-
vation, tum
ors and the nerv-
ous system
 pathologies pre-
sent the future areas of inte-
rest.
- Operates in:Italy, France,
UK, Canada, USA, M
exico
and United Arab Em
irates.
- Num
ber of licensing agree-
m
ents:60.
Com
pany Info
Com
pany B licenses only finished pro-
ducts, so they transfer m
ainly the
know-how, dossiers and secrets not
covered by patent.  Their licensing
agreem
ents are also supply agree-
m
ents for the finished products. The
first product from
 Com
pany B today is
a liquid solution for the vitam
in D-3,
which will probably secure the survi-
val of the com
pany in the next years.
Com
pany B is now searching for a
partner for the authorization and dis-
tribution of the product in the m
ain
European countries. They are working
hard on the life cycle m
anagem
ent, in
order to understand which new pro-
ducts can be created around the sam
e
m
olecules. On the other side, com
pa-
ny is also im
proving their business
intelligence activities in the other
m
arkets.
Exam
ples of licensing projects as the
foreign m
arket entry m
ode
- Intelligence:Com
pany B screens the com
pa-
nies in the m
arket that are active in the sam
e
therapeutic field (e.g. the product for tum
or
they license in Canada, they explore the com
-
panies that are active only for this specific
tum
or), explore the real m
arket size (by pur-
chasing data or doing research by them
selves)
and cultural differences of the countries. They
observe their product portfolio of the local
com
panies, size of the com
pany (long decision
tim
ing in larger com
panies m
ay cause pro-
blem
s). Com
pany B uses dedicated organized
m
eetings, conferences or specialized fairs to
contact partners. 
- Negotiation: Com
pany B does a m
ultiple
stage negotiation. Norm
ally, all the aspects of
cooperation they com
bine in one agreem
ent
that includes a know-how licensing agree-
m
ent, tradem
ark license agreem
ent and sup-
ply agreem
ent of the finished product.
- Control: Com
pany B has a dedicated functio-
nal unit that works only with licensing agree-
m
ents. It does not only control the contract
m
anagem
ent, but also an alliance m
anage-
m
ent.This is done through periodic phone
conferences and m
eetings, where they observe
the com
m
itm
ent of the partner com
pany.
Com
pany B introduces the control of yearly
achievem
ent of the m
inim
um
 quantities of
sales. 
Recognized licensing stages
Journal of Business Chemistry 2013, 10 (1)© 2013 Institute of Business Administration 18
Com
pany C
Com
pany
Com
pany C is one of Italy's
leading biopharm
aceutical
com
panies, with a solid his-
tory of developing innovati-
ve drugs for illnesses of high
social im
pact.
- Turnover: €491 m
illion
(data from
 2009).
- Em
ployees:800
- Core business:Leadership
in core areas
of anti-inflam
m
atory, respi-
ratory, rare diseases, neuro-
logy, onco/ hem
atology and
nephrology.
- Operate in:Italy, Germ
any,
Belgium
, Spain, Portugal,
Poland, Greece, Albania, Tur-
key, Russia, Kazakhstan,
Korea, Hong Kong, Azerbai-
jan, Arm
enia, Uzbekistan,
Uzbekistan, Tajikistan, M
exi-
co, Dom
inican Republic,
Venezuela, Brazil, Colum
bia,
Peru and Chile.
- Num
ber of licensing agree-
m
ents:Not available
Com
pany Info
Com
pany C was present in Russia, but
was not satisfied with the results and
wanted to change the partner. The old
partner was not a local com
pany, it
was an Indian com
pany, and it had a
lot of products that were com
peting
with Com
pany C products. So, they
found a local partner that was also
able to cover the form
er Soviet Union
countries and Eastern Europe (a regio-
nal player). The strategy was to give
all the portfolio of the com
pany to the
partner. The m
ain products in this
deal are: a drug for treatm
ent of
inflam
m
ation associated with pain
(the m
ost im
portant product of Com
-
pany C) and m
ucolytic drug for chro-
nic and acute respiratory diseases.
Com
pany C generally supplies with
the finished product when entering a
new m
arket, because it is the way to
keep it secret even when the generic
production becom
es available. 
Exam
ples of licensing projects as the
foreign m
arket entry m
ode
- Intelligence:Com
pany C starts with m
arket
analysis perform
ed by the dedicated functional
unit for licensing. It has a form
alized process
for evaluation of potential partners, which con-
sists of:  Identification of a “Long List” of phar-
m
aceutical com
panies belonging to the m
ain
National  Trade Associations; Gathering of
public available inform
ation relevant to assess
partner’s “generic and specific requirem
ents”;
Exclusion of com
panies with a clear business
m
odel unfit assessed through the analysis of
their product portfolio and stated m
ission (e.g.:
generic com
panies, specialty-R&D com
panies,
hom
eopathic com
panies...); In depth desk ana-
lysis and profiling of short listed com
panies;
First ranking of short listed com
panies based
on: Product Portfolio Fit(therapeutic field,
num
ber of drugs, the expertise they have on
the regulatory activities, presence in other m
ar-
kets) and Econom
ic and Financial Soundness
(financial foundation of the com
pany).
- Realization:Com
pany C m
ade a m
arketing
support (the inform
ation and knowledge to
enter the m
arket) for the partnering com
pany.
It includes the Italian and foreign partners
experiences. The m
ain aim
 is to help them
understand how the product works and which
its benefits on which they should focus are. 
- Control:Partners needed to send annual m
ar-
keting plan, attend m
eetings m
ade to check
the progress of registration and sales, send
m
onthly reports containing sales data, com
-
m
ents on sales perform
ance and inform
ation
on generic products.
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Com
pany D
Com
pany
Com
pany D is one of the lea-
ding Italian pharm
aceutical
groups, operates in both the
pharm
aceutical and the fine
chem
ical industries.
- Turnover:€ 500 m
illion
(around 24% from
 foreign
m
arkets)
- Em
ployees:2000
- Core business:Its products,
all of which have a high the-
rapeutic content, are m
ainly
used in the cardiovascular,
im
m
uno-oncological, gynae-
cological, derm
atological,
orthopaedic and neurologi-
cal areas. 
- Operate in:Italy, Russia,
Brazil, Turkey, Greece, Chile,
Portugal, USA, Spain, France,
M
orocco, Albania, M
acedo-
nia, Bulgaria, Rom
ania,
China, Korea, Vietnam
, Iran,
Iraq, Egypt, Libya, Algeria,
Sudan, Kenya, Georgia…)
- Num
ber of licensing agree-
m
ents:50-60 
Com
pany Info
Com
pany D licenses the right to pro-
duce the finished product from
 the
raw m
aterial com
pany produces. This
is their approach in Korea, Turkey and
Greece. The product is the iron com
-
pound, which is their innovation
breakthrough. It is iron bound with
m
ilk protein (casein). Com
pany D has
this sophisticated binding that is very
tight in condition of low PH. W
hen a
patient drinks it, it goes to the sto-
m
ach, where the level of PH is very
low, so the biding of the protein
towards the iron is very tight and no
iron is released in the stom
ach. W
hen
this com
plex flows into intestine,
where PH is very high, the proteins are
im
m
ediately digested and iron is
released and absorbed. In the com
-
m
on treatm
ent of iron deficiency
anaem
ia, one of the m
ajor side effects
is the gastritis problem
, especially in
the pregnant wom
en. W
ith this pro-
duct these classic iron side effects are
avoided. It was released in the early
90s. In som
e countries there are gene-
ric producers of this com
pound. Com
-
pany com
m
itted a lot of resources to
carefully protect this com
pound.
Exam
ples of licensing projects as the
foreign m
arket entry m
ode
- Intelligence:Com
pany D looks at all the coun-
tries and finds up to 5 potential countries.
Then identify all those possible partners that
in these countries could bring their product to
target doctors. Com
pany observes in potential
partners their structure, portfolio of products,
if they had synergies with their portfolio, their
sales, their presence in the field, financial
capabilities, technical capabilities and com
-
m
ercial capabilities. These data is collected
through databank, m
eetings, personal con-
nections and consultants.
- Negotiation:After identifying the partner
Com
pany D goes with the licensing deal,
where they reveal: what, how, in which way
and in which tim
ing they have to do. Funda-
m
entally, the question of tim
e is observed.
- Realization:It can be a transfer of know-how,
or it can be even a com
m
ercial know-how. It
depends on what kind of technology is trans-
ferred. If the rights for production are also
transferred, the com
pany helps the partner to
produce, follows them
 and inform
s and advi-
ses them
. It depends who is their partner,
what kind of technology are they transferring.
- Control:The bigger is the com
pany, the m
ore
autonom
ous they are and m
ore difficult is to
follow the project. Com
pany D follows the
m
ilestones they put in agreem
ent and key
tim
es for the fulfilm
ent of the tasks. Again, the
point of tim
e is m
ore contractual than ever.
Recognized licensing stages
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Dynamic Capabilities by code
Com
panies
Reconfiguring Seizing Sensing
3.3 3.2 3.1 2.2 2.1 1.2 1.1
P
Com
pany A
Process Stages
√ √ I
√ √ N
R
C
P
Com
pany B
Process Stages
√ √ I
√ √ N
R
√ √ √ C
P
Com
pany C
Process Stages
√ √ I
N
√ √ R
√ C
P
Com
pany D
Process Stages
√ √ I
√ √ √ √ √ N
√ √ R
√ C
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